| |
| |
|
| Insider
Information: |
Schneyer Mark C. |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
28,742 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$480,279 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,742 |
|
|
| Total
Value |
$480,279 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acadia Pharmaceuticals Inc |
ACAD |
|
2024-04-08 |
28,742 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACAD |
Acadia Pharmaceuticals In... |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2024-04-08 |
4 |
AS |
$17.87 |
$48,535 |
D/D |
(2,716) |
28,742 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2024-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,275 |
31,458 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2024-03-27 |
4 |
AS |
$17.90 |
$97,269 |
D/D |
(5,434) |
26,183 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2024-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
31,617 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2024-02-26 |
4 |
AS |
$24.67 |
$19,045 |
D/D |
(772) |
21,067 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2024-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,353 |
21,839 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-11-20 |
4 |
S |
$22.64 |
$115,645 |
D/D |
(5,108) |
20,486 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,912 |
25,594 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-08-21 |
4 |
AS |
$29.00 |
$289,970 |
D/D |
(10,000) |
15,682 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-06-08 |
4 |
S |
$25.02 |
$24,369 |
D/D |
(974) |
22,824 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,893 |
23,798 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-05-17 |
4 |
S |
$22.50 |
$344,475 |
D/D |
(15,310) |
21,905 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,738 |
37,215 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-04-06 |
4 |
S |
$18.16 |
$34,795 |
D/D |
(1,916) |
7,477 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,275 |
9,393 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-02-24 |
4 |
S |
$18.78 |
$10,836 |
D/D |
(577) |
4,118 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2023-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,353 |
4,695 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2022-06-09 |
4 |
S |
$17.91 |
$11,695 |
D/D |
(653) |
3,342 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP, Chief Financial Officer |
• – – |
2022-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,893 |
3,995 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2022-02-23 |
4 |
S |
$23.80 |
$13,161 |
D/D |
(553) |
2,102 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2022-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,352 |
2,655 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
Chief Financial OfficerOfficer |
• – – |
2021-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,303 |
|
% |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
